BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bhat A, Sebastiani G, Bhat M. Systematic review: Preventive and therapeutic applications of metformin in liver disease. World J Hepatol 2015; 7(12): 1652-1659 [PMID: 26140084 DOI: 10.4254/wjh.v7.i12.1652]
URL: https://www.wjgnet.com/1007-9327/full/v7/i12/1652.htm
Number Citing Articles
1
Lu Cai, Kai Hu, Ling Lin, Qing Ai, Pu Ge, Yiqing Liu, Jie Dai, Bin Ye, Li Zhang. AMPK dependent protective effects of metformin on tumor necrosis factor-induced apoptotic liver injuryBiochemical and Biophysical Research Communications 2015; 465(3): 381 doi: 10.1016/j.bbrc.2015.08.009
2
Laura Iogna Prat, Emmanuel A. Tsochatzis. The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD)Hormones 2018; 17(2): 219 doi: 10.1007/s42000-018-0021-9
3
Practical Diabetes Care2018; : 241 doi: 10.1002/9781119052210.ch10
4
Zhe Zheng, Yue Li, Siyuan Fan, Jie An, Xi Luo, Minglu Liang, Feng Zhu, Kai Huang. WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1Cell Death & Disease 2021; 12(3) doi: 10.1038/s41419-021-03536-8
5
Rong Shi, Xining Xu, Jiasheng Wu, Tianming Wang, Yuanyuan Li, Bingliang Ma, Yueming Ma. Hydrophilic interaction chromatography-tandem mass spectrometry based on an amide column for the high-throughput quantification of metformin in rat plasmaRSC Advances 2015; 5(123): 101386 doi: 10.1039/C5RA20500J
6
Wei Wu, Jun-Ling Yang, Yi-Lang Wang, Han Wang, Min Yao, Li Wang, Juan-Juan Gu, Yin Cai, Yun Shi, Deng-Fu Yao. Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting <i>NF-&kappa;B</i> gene transcriptionWorld Journal of Hepatology 2016; 8(23): 985-993 doi: 10.4254/wjh.v8.i23.985
7
Rejane Augusta de Oliveira Figueiredo, Elisabete Weiderpass, Eloiza Helena Tajara, Peter Ström, André Lopes Carvalho, Marcos Brasilino de Carvalho, Jossi Ledo Kanda, Raquel Ajub Moyses, Victor Wünsch-Filho. Diabetes mellitus, metformin and head and neck cancerOral Oncology 2016; 61: 47 doi: 10.1016/j.oraloncology.2016.08.006
8
Xu Li, Hongqin Xu, Yang Gao, Meng Pan, Le Wang, Pujun Gao. Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in ChinaMedicine 2017; 96(13): e6508 doi: 10.1097/MD.0000000000006508
9
Chenggui Miao, Zhongwen Xie, Jun Chang. Critical Roles of microRNAs in the Pathogenesis of Fatty Liver: New Advances, Challenges, and Potential DirectionsBiochemical Genetics 2018; 56(5): 423 doi: 10.1007/s10528-018-9870-9
10
Daniela Maria Tanase, Evelina Maria Gosav, Claudia Florida Costea, Manuela Ciocoiu, Cristina Mihaela Lacatusu, Minela Aida Maranduca, Anca Ouatu, Mariana Floria. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)Journal of Diabetes Research 2020; 2020: 1 doi: 10.1155/2020/3920196
11
Ans Jacobs, Anne‐Sophie Warda, Jef Verbeek, David Cassiman, Pieter Spincemaille. An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to PresentCurrent Protocols in Mouse Biology 2016; 6(2): 185 doi: 10.1002/cpmo.3
12
Ashwini Arvind, Zoe N. Memel, Lisa L. Philpotts, Hui Zheng, Kathleen E. Corey, Tracey G. Simon. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysisMetabolism 2021; 120: 154780 doi: 10.1016/j.metabol.2021.154780
13
Stephen Safe, Vijayalekshmi Nair, Keshav Karki. Metformin-induced anticancer activities: recent insightsBiological Chemistry 2018; 399(4): 321 doi: 10.1515/hsz-2017-0271
14
Soraya J Kaewpitoon, Ryan A Loyd, Ratana Rujirakul, Sukij Panpimanmas, Likit Matrakool, Taweesak Tongtawee, Nusorn Kootanavanichpong, Ponthip Kompor, Wasugree Chavengkun, Jirawoot Kujapun, Jun Norkaew, Sukanya Ponphimai, Natnapa Padchasuwan, Poowadol Pholsripradit, Thawatchai Eksanti, Tanida Phatisena, Natthawut Kaewpitoon. Benefits of Metformin Use for CholangiocarcinomaAsian Pacific Journal of Cancer Prevention 2016; 16(18): 8079 doi: 10.7314/APJCP.2015.16.18.8079
15
Betül Evran, Abdurrahman Fatih Aydın, Buse Uğuralp, Mehmet Sar, Semra Doğru-Abbasoğlu, Müjdat Uysal. Betaine treatment decreased serum glucose and lipid levels, hepatic and renal oxidative stress in streptozotocin-induced diabetic ratsTurkish Journal of Biochemistry 2018; 43(4): 343 doi: 10.1515/tjb-2016-0183
16
Marco Sacco, Davide Giuseppe Ribaldone, Giorgio Maria Saracco. Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?Viruses 2023; 15(12): 2451 doi: 10.3390/v15122451
17
Narges Hedayati, Zahra Oskouei, Jamshid Tabeshpour, Mehri Bemani Naeini. Berberine and lycopene as alternative or add-on therapy to metformin and statins, a reviewEuropean Journal of Pharmacology 2021; 913: 174590 doi: 10.1016/j.ejphar.2021.174590
18
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran. Non-alcoholic Fatty Liver Disease: A Clinical UpdateJournal of Clinical and Translational Hepatology 2017; (XX): XX doi: 10.14218/JCTH.2017.00013
19
Brennan K. Smith, Katarina Marcinko, Eric M. Desjardins, James S. Lally, Rebecca J. Ford, Gregory R. Steinberg. Treatment of nonalcoholic fatty liver disease: role of AMPKAmerican Journal of Physiology-Endocrinology and Metabolism 2016; 311(4): E730 doi: 10.1152/ajpendo.00225.2016
20
Mohammed Alqarni, Abdullah A. Alshehri, Hassan Arida, Mahmood Ahmed. Validation and Application of Screen-Printed Microchip for Potentiometric Determination of Metformin Hydrochloride in Tablet Dosage FormInternational Journal of Analytical Chemistry 2024; 2024: 1 doi: 10.1155/2024/8664723
21
Felix Gundling. Der hepatogene Diabetes – aktueller Stand der Diagnostik und TherapieJournal für Klinische Endokrinologie und Stoffwechsel 2022; 15(2): 42 doi: 10.1007/s41969-022-00158-z
22
Kuo Du, Anup Ramachandran, James L. Weemhoff, Hemantkumar Chavan, Yuchao Xie, Partha Krishnamurthy, Hartmut Jaeschke. Editor’s Highlight: Metformin Protects Against Acetaminophen Hepatotoxicity by Attenuation of Mitochondrial Oxidant Stress and DysfunctionToxicological Sciences 2016; 154(2): 214 doi: 10.1093/toxsci/kfw158
23
Ulfa Kholili, Alvin Hartanto Kurniawan, Choirina Winda, Ummi Maimunah, Poernomo Budi Setiawan. The Role of Metformin as Chemopreventive Strategies for Hepatocellular CarcinomaResearch Journal of Pharmacy and Technology 2023; : 377 doi: 10.52711/0974-360X.2023.00065
24
Xue Yu, Yan Wang, Jianming Lai, Ting Song, Jianping Duan. Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysisIrish Journal of Medical Science (1971 -) 2023; 192(1): 131 doi: 10.1007/s11845-022-02988-x
25
T. Yu. Demidova, M. Ya. Izmailova, K. M. Belova, V. V. Titova. New prospects for the interdisciplinary use of metformin in clinical practice: its role in the treatment of non-alcoholic fatty liver diseaseFOCUS. Endocrinology 2023; 4(3): 41 doi: 10.15829/2713-0177-2023-3-14
26
Yoshihito Fujita, Nobuya Inagaki. Metformin: New Preparations and Nonglycemic BenefitsCurrent Diabetes Reports 2017; 17(1) doi: 10.1007/s11892-017-0829-8
27
André J. Scheen. Comparative effects between old and new antidiabetic agents on metabolic- associated fatty liver disease (MAFLD)Diabetes Epidemiology and Management 2023; 11: 100145 doi: 10.1016/j.deman.2023.100145
28
Abdulrahman Ismaiel, Dan L. Dumitrascu. How to Reduce Cardiovascular Risk in Nonalcoholic Fatty Liver DiseaseAmerican Journal of Therapeutics 2023; 30(3): e242 doi: 10.1097/MJT.0000000000001174
29
Preetam Nath, Anil C. Anand. Hepatogenous Diabetes: A PrimerJournal of Clinical and Experimental Hepatology 2021; 11(5): 603 doi: 10.1016/j.jceh.2021.04.012
30
John Vizuete, Alfredo Camero, Mazyar Malakouti, Karthik Garapati, Julio Gutierrez. Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future TherapiesJournal of Clinical and Translational Hepatology 2017; 5(1): 67 doi: 10.14218/JCTH.2016.00061
31
Jonggi Choi, Lewis R. Roberts. Statins and metformin for chemoprevention of hepatocellular carcinomaClinical Liver Disease 2016; 8(2): 48 doi: 10.1002/cld.568
32
Xiaoyan Xu, Yaqin Sun, Xufeng Cen, Bing Shan, Qingwei Zhao, Tingxue Xie, Zhe Wang, Tingjun Hou, Yu Xue, Mengmeng Zhang, Di Peng, Qiming Sun, Cong Yi, Ayaz Najafov, Hongguang Xia. Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse modelProtein & Cell 2021; 12(10): 769 doi: 10.1007/s13238-021-00858-3
33
Shalini Sivadasan, Muthukumar Subramanian, Rajasekaran Aiyalu. Metformin - Pharmacology and Drug Interactions2021;  doi: 10.5772/intechopen.99815
34
Antje Garten, Susanne Schuster, Melanie Penke. Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma?Expert Review of Anticancer Therapy 2017; 17(4): 289 doi: 10.1080/14737140.2017.1298447
35
Niloofar Haghdadi, Sakineh Asghari, Ghasem Firouzzadeh Pasha. Synthesis and characterization of functionalized nano NaY zeolite with metformin and use for the synthesis of 2-amino-4H-chromenesResearch on Chemical Intermediates 2024; 50(5): 1961 doi: 10.1007/s11164-024-05258-w
36
Fu-Shun Yen, Chih-Cheng Hsu, James Cheng-Chung Wei, Ming-Chih Hou, Chii-Min Hwu. Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver DiseaseFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.839456
37
Anna Simona Sasdelli, Lucia Brodosi, Giulio Marchesini. NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic DisordersCurrent Hepatology Reports 2016; 15(2): 103 doi: 10.1007/s11901-016-0297-7
38
Raul D. Santos, Luca Valenti, Stefano Romeo. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gapsAtherosclerosis 2019; 282: 110 doi: 10.1016/j.atherosclerosis.2019.01.029
39
Lena Schulte, Bernhard Scheiner, Torsten Voigtländer, Sandra Koch, Nora Schweitzer, Silke Marhenke, Philipp Ivanyi, Michael P. Manns, Thomas Rodt, Jan B. Hinrichs, Arndt Weinmann, Matthias Pinter, Arndt Vogel, Martha M. Kirstein. Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinomaLiver International 2019; 39(4): 714 doi: 10.1111/liv.14048
40
Roberto Romero, Offer Erez, Maik Hüttemann, Eli Maymon, Bogdan Panaitescu, Agustin Conde-Agudelo, Percy Pacora, Bo Hyun Yoon, Lawrence I. Grossman. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevityAmerican Journal of Obstetrics and Gynecology 2017; 217(3): 282 doi: 10.1016/j.ajog.2017.06.003
41
Thanida Tangjarusritaratorn, Watip Tangjittipokin, Tada Kunavisarut. Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without MetforminDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1563 doi: 10.2147/DMSO.S295753
42
L. Yu. Morgunov. DIABETES MELLITUS IN PATIENTS WITH LIVER CIRRHOSIS: NEW TREATMENT OPTIONSResearch'n Practical Medicine Journal 2017; 4(3): 75 doi: 10.17709/2409-2231-2017-4-3-7
43
Yun‐Shan Wang, Lutao Du, Xingsi Liang, Peng Meng, Lei Bi, Yu‐li Wang, Chuanxin Wang, Bo Tang. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine‐Monophosphate–Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in MiceHepatology 2019; 69(4): 1614 doi: 10.1002/hep.30421
44
Yuansheng Liu, Qian Zhang, Lei Yang, Wencong Tian, Yinan Yang, Yuhang Xie, Jing Li, Liang Yang, Yang Gao, Yang Xu, Jie Liu, Yachen Wang, Jie Yan, Guoxun Li, Yanna Shen, Zhi Qi. Metformin Attenuates Cardiac Hypertrophy Via the HIF-1α/PPAR-γ Signaling Pathway in High-Fat Diet RatsFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.919202
45
Chaofu Li, Yating Deng, Yating Pan, Xinyi Liao, Huadong Xie, Xiaoli Xue, Shaoqing Yu, Wenlong Yu, Guanzhen Yu. Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learningHeliyon 2024; 10(18): e37347 doi: 10.1016/j.heliyon.2024.e37347
46
Deepika Kathuria, Akshay D. Raul, Pravin Wanjari, Prasad V. Bharatam. Biguanides: Species with versatile therapeutic applicationsEuropean Journal of Medicinal Chemistry 2021; 219: 113378 doi: 10.1016/j.ejmech.2021.113378
47
Maria Corina Plaz, Emmanuel A. Tsochatzis. Textbook of Liver Transplantation2022; : 357 doi: 10.1007/978-3-030-82930-8_20
48
Rebekka Pohl, Elisabeth M. Haberl, Lisa Rein‐Fischboeck, Sebastian Zimny, Maximilian Neumann, Charalampos Aslanidis, Doris Schacherer, Sabrina Krautbauer, Kristina Eisinger, Thomas S. Weiss, Christa Buechler. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitisEuropean Journal of Clinical Investigation 2017; 47(1): 7 doi: 10.1111/eci.12695
49
Everton Cazzo, José Carlos Pareja, Elinton Adami Chaim. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive reviewSao Paulo Medical Journal 2017; 135(3): 277 doi: 10.1590/1516-3180.2016.0306311216
50
Abdulrahman Ismaiel, Dan L. Dumitraşcu. Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature ReviewFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00202
51
Z A Kalmykova, I V Kononenko, A Yu Mayorov. Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment featuresTerapevticheskii arkhiv 2019; 91(12): 115 doi: 10.26442/00403660.2019.12.000166
52
Noor Sharrack, Kristopher D. Knott, Gaurav S. Gulsin, Tushar Kotecha, Louise A. E. Brown, Jian L. Yeo, Aldostefano Porcari, Robert D. Adam, Sharmaine Thirunavukarasu, Amrit Chowdhary, Eylem Levelt, James C. Moon, Gerry P. McCann, Marianna Fontana, Peter Kellman, Theresa Munyombwe, Chris P. Gale, David L. Buckley, John P. Greenwood, Peter P. Swoboda, Sven Plein. Metformin associates with higher myocardial perfusion reserve and survival in type 2 diabetes mellitus patientsScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-77280-2
53
Andrea Boccatonda, Damiano D’Ardes, Veronica Moronti, Jessica Santilli, Alessia Cipollone, Gianfranco Lessiani, Nicoletta Di Gregorio, Carla Serra, Fabio Piscaglia, Claudio Ferri, Francesco Cipollone. From MASLD to PAD: Looking for Cardiovascular Disease Starting from Metabolic StatusMedicina 2024; 60(11): 1781 doi: 10.3390/medicina60111781
54
Mehrnaz Abbasi, Braeden Heath, Lauren McGinness. Advances in metformin‐delivery systems for diabetes and obesity managementDiabetes, Obesity and Metabolism 2024; 26(9): 3513 doi: 10.1111/dom.15759
55
Catalina Mihai, Bogdan Mihai, Cristina Cijevschi Prelipcean. Essentials of Non-Alcoholic Fatty Liver Disease2023; : 159 doi: 10.1007/978-3-031-33548-8_14
56
Diego García-Compeán, Emanuela Orsi, Ramesh Kumar, Felix Gundling, Tsutomu Nishida, Jesús Zacarías Villarreal-Pérez, Ángel N Del Cueto-Aguilera, José A González-González, Giuseppe Pugliese. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectivesWorld Journal of Gastroenterology 2022; 28(8): 775-793 doi: 10.3748/wjg.v28.i8.775
57
André J. Scheen. Pharmacokinetic, toxicological, and clinical considerations for the treatment of type 2 diabetes in patients with liver disease: a comprehensive updateExpert Opinion on Drug Metabolism & Toxicology 2023; 19(8): 543 doi: 10.1080/17425255.2023.2252333
58
Laura Belloni, Silvia Di Cocco, Francesca Guerrieri, Abigail D. G. Nunn, Silvia Piconese, Debora Salerno, Barbara Testoni, Claudio Pulito, Federica Mori, Matteo Pallocca, Andrea Sacconi, Elisa Vivoli, Fabio Marra, Sabrina Strano, Giovanni Blandino, Massimo Levrero, Natalia Pediconi. Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo modelScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-31835-2
59
Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Luca Valenti. The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?Expert Review of Gastroenterology & Hepatology 2016; 10(2): 229 doi: 10.1586/17474124.2016.1110018
60
Jinqing Wu, Yabo Zhou, Guizhou Wang, Nicola Silvestris. Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, ChinaGastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/9468227
61
Atsushi Sawamoto, Madoka Okada, Nanako Matsuoka, Satoshi Okuyama, Mitsunari Nakajima. Tipepidine activates AMPK and improves adipose tissue fibrosis and glucose intolerance in high‐fat diet‐induced obese miceThe FASEB Journal 2024; 38(5) doi: 10.1096/fj.202301861RR
62
Sofia de Oliveira, Ruth A. Houseright, Alyssa L. Graves, Netta Golenberg, Benjamin G. Korte, Veronika Miskolci, Anna Huttenlocher. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafishJournal of Hepatology 2019; 70(4): 710 doi: 10.1016/j.jhep.2018.11.034
63
Ziquan Lv, Yajie Guo. Metformin and Its Benefits for Various DiseasesFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00191